Search Global Export Import Trade Data
Recent Searches: No Recent Searches

Centre's investor-friendly policy makes SEZ vibrant in Gujarat.

Date: 06-04-2016
Subject: Centre's investor-friendly policy makes SEZ vibrant in Gujarat
New Delhi, Apr 5 (ANI): The Modi government's much touted campaign of 'Make in India' and the Department of Industrial Promotion and Policy's (DIPP) efforts to push 'Ease of doing Business' has started paying dividends with Special Economic Zones (SEZs) becoming the most favorite investment destinations.

The latest among the recent investments is Gujarat based SEZ, which attracted Rs. 100 crore investment for a Pharma sector Research and Development Centre.

A state-of-the-art research and development centre 'Navin Saxena Research and Technology'(NSRT), Clinical research organization, 'Quest Care' and a specialized manufacturing unit for transdermal patches was launched today at the Kandla SEZ.

The facility, owned by parent company Rusan Pharma Ltd, is the only one in the country to manufacture Nicotine transdermal patches in India. Set up in alignment with the PM's 'Make in India' initiative, it is expected go a long way in making the Kandla SEZ vibrant and investor-friendly.

The new establishment at Kandla houses three subsidiaries, namely the Navin Saxena Research and Technology (NSRT) Centre, Quest Care, which is the company's clinical research organization and Rusan's dedicated Transdermal Patch Facility.

Together, these three units will handle the myriad aspects of addiction and pain management drug manufacture and export as a part of their portfolio, including research and innovation, licensing, IPR, patenting, quality assurance.

They offer immense employment opportunities not only to the local population but also to highly qualified scientists from India and abroad.

A senior official of DIPP said, "Things are moving forward and fast. The government is sensitive about the immediate requirements of the investors. For Pharma sector regulations and rules are being simplified and streamlined. An investor-friendly policy is already in place."

NSRT is a dedicated research and development facility that has state-of-the-art technology and equipment. Research at NSRT will focus on pain, addiction, CNS and orphan diseases, drug delivery and platform technologies.

It has been set up with a vision to develop, register and license its new products to third parties. It also aims to undertake contract research and joint development projects.

Rusan group companies together have a current turnover of Rs. 300 crore and intend to grow to 600 crore in 2018. Being the first Indian company to do research on addiction and disease, they intend to expand their new facility with an investment of Rs. 100 crore in next year.

Dr. Navin Saxena, Chairman and Founder of Rusan Pharma Ltd, said, "With our continuous efforts and innovation we are proud to announce the biggest government and private Indian company deal between Brazil Health Ministry and Rusan Pharma Ltd. for USD 20 million per annum for their program for smoking cessation."

To push collaborative research, a multi-party memorandum of understanding (MoU) was signed on the occasion between NSRT, Moscow State University (Russia), Symbiosis College Pune, the Maharaja Sayajirao University of Baroda and IIT Kanpur.

"The MoU highlights NSRT's commitment to collaborative research. This would further flare up reverse brain drain for Indian students," Dr Saxena said.

Source : timesofindia.indiatimes.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Exim Help

What is New?

Date: 22-11-2023
Notification No. 13/2023 -Customs (ADD)
Seeks to further amend notification No. 47/2021-Customs (ADD), dated 26th August, 2021, imposing Anti-dumping Duty on imports of "Natural mica-based pearl industrial pigments excluding cosmetic grade" from China PR, to modify the existing duty table .

Date: 21-11-2023
NOTIFICATION No. 12/2023-Customs (ADD)
Seeks to continue levy of anti-dumping duty on "Synthetic Grade Zeolite 4A (Detergent Grade) from China PR for 5 years pursuant to First Sunset Review Final Findings issued by DGTR."

Date: 17-11-2023
NOTIFICATION No. 11/2023-Customs (ADD)
seeks to impose anti-dumping duty on toughened glass for home appliances imported from China PR for a period of 5 years.

Date: 17-11-2023
NOTIFICATION No. 54/2023- Central Tax
Seeks to amend Notification No. 27/2022 dated 26.12.2022 to notify biometric-based Aadhaar authentication for GST registration in the State of Andhra Pradesh.

Date: 16-11-2023
Notification No. 84/2023 - Customs (N.T.)
Exchange Rate Notification No. 84/2023-Cus (NT) dated 16.11.2023-reg

Date: 15-11-2023
Notification No. 83/2023 - Customs (N.T.)
Exchange Rate Notification No. 83/2023-Cus (NT) dated 15.11.2023-reg

Date: 15-11-2023
Notification No. 82/2023-CUSTOMS (N.T.)
Fixation of Tariff Value of Edible Oils, Brass Scrap, Areca Nut, Gold and Silver- Reg.

Date: 02-11-2023
Notification No. 16/2023- Union Territory Tax (Rate)
Seeks to amend Notification No 17/2017- Union territory Tax (Rate) dated 28.06.2017.

Date: 02-11-2023
Seeks to notify a special procedure for condonation of delay in filing of appeals against demand orders passed until 31st March, 2023.

Date: 02-11-2023
Notification No. 81/2023 - Customs (N.T.)
Exchange Rate Notification No. 81/2023-Cus (NT) dated 02.11.2023-reg

Exim Guru Copyright © 1999-2023 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.


C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001